Data availability
Not applicable.
References
World Health Organization. Cannabis. https://www.who.int/teams/mental-health-and-substance-use/alcohol-drugs-and-addictive-behaviours/drugs-psychoactive/cannabis. Accessed 28 Jan 2023
Page R, Allen L, Kloner R, Carriker C, Martel C, Morris A et al (2020) Medical marijuana, recreational cannabis, and cardiovascular health: a scientific statement from the American Heart Association. Circulation 142(10):e131–e152
Quattrone D, Ferraro L, Tripoli G, La Cascia C, Quigley H, Quattrone A et al (2021) Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case–control study. Psychol Med 51(8):1329–1337
Substance Abuse and Mental Health Services Administration. Center for behavioral health statistics and quality. 2019 national survey on drug use and health: Detailed tables. 2020. https://www.samhsa.gov/data/report/2019-nsduh-detailed-tables. Accessed 28 Jan 2023
Shah S, Schwenk ES, Sondekoppam RV, Clarke H, Zakowski M, Rzasa-Lynn RS et al (2023) ASRA Pain Medicine consensus guidelines on the management of the perioperative patient on cannabis and cannabinoids. Reg Anesth Pain Med 48(3):97–117
Committee opinion summary NO. 722: Marijuana use during pregnancy and lactation. Obstetrics and gynecology (New York. 1953). 2017;130(4):931–932. https://www.ncbi.nlm.nih.gov/pubmed/28937569. https://doi.org/10.1097/AOG.0000000000002349
Dharmapuri S, Miller K, Klein JD (2020) Marijuana and the pediatric population. Pediatrics 146(2):1
Funding
Research reported in this manuscript was supported by the International Academy on the Science and Impact of Cannabis. The content is solely the responsibility of the authors and does not necessarily represent the official views of the International Academy on the Science and Impact of Cannabis.
Author information
Authors and Affiliations
Contributions
In regard to the authors, all the co-authors qualify for authorship based on the ICMJE criteria for authorship. Specifically, all the authors were involved in the drafting of this manuscript. Moreover, all the co-authors participated in: (1) The manuscript’s intellectual content, analysis of the data, and participating in its writing. (2) The manuscript’s review of the final version, approved its publication, and certified the accuracy and integrity of the final product. (3) The certification stated that the manuscript neither has been published elsewhere nor has any rights to a third party.
Corresponding author
Ethics declarations
Ethics approval/consent
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Finn, K., Bakewell, B.K. Cannabis education: how providers and patients can engage in discussion. Int J Legal Med 137, 1439–1440 (2023). https://doi.org/10.1007/s00414-023-03041-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00414-023-03041-x